Inhibitors of Akt activity

Details for Australian Patent Application No. 2007327992 (hide)

Owner Merck & Co., Inc.

Inventors Sanderson, Philip E.; Rodzinak, Kevin J.; Layton, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-A-2007327992

PCT Pub. Number WO2008/070134

Priority 60/873,192 06.12.06 US

Filing date 4 December 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

C07D 253/00 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/070134 Priority application(s): WO2008/070134

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007327993-Methods of treating systemic lupus erythematosus

2007327991-Systems and methods for media source selection and toggling